TELA Bio, Inc. (TELA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, TELA Bio, Inc. reported revenue of $80.28M, up 15.8% from the prior year. The company ran a net loss, with a net margin of -48.4% and a gross margin of 67.7%. It held $81.42M in total assets against $75.11M in total liabilities.
Key ratios (FY2025)
67.7%
Gross margin
-42.0%
Operating margin
-48.4%
Net margin
-615.1%
Return on equity
+15.8%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80.28M | $69.30M | $58.45M | $41.42M | $29.46M | $18.21M | $15.45M | $8.27M | $4.25M | — |
| Gross Profit | $54.34M | $46.49M | $40.11M | $27.04M | $18.81M | $11.23M | $9.27M | $2.94M | $2.53M | — |
| Operating Income | -$33.76M | -$34.12M | -$44.08M | -$39.01M | -$29.45M | -$25.27M | -$19.16M | -$17.78M | -$16.92M | — |
| Net Income | -$38.83M | -$37.84M | -$46.66M | -$44.30M | -$33.28M | -$28.79M | -$22.43M | -$21.09M | -$21.33M | — |
| EPS (Diluted) | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 | $-2.23 | $-17.10 | — | — | — |
| Total Assets | $81.42M | $86.57M | $78.05M | $67.86M | $62.54M | $86.46M | $67.92M | $27.23M | — | — |
| Total Liabilities | $75.11M | $58.11M | $59.17M | $53.55M | $42.45M | $37.43M | $36.96M | $40.94M | — | — |
| Shareholders' Equity | $6.31M | $28.46M | $18.88M | $14.30M | $20.10M | $49.03M | $30.96M | -$137.86M | -$108.17M | -$81.17M |
| Cash & Equivalents | $50.84M | $52.67M | $46.73M | $42.02M | $43.93M | $74.39M | $45.30M | $17.28M | — | — |
| Operating Cash Flow | -$28.22M | -$41.59M | -$40.86M | -$40.75M | -$30.43M | -$24.46M | -$25.52M | -$19.92M | -$16.37M | — |
| Capital Expenditures | $448.0K | $989.0K | $611.0K | $872.0K | $627.0K | $167.0K | $197.0K | $62.0K | $114.0K | — |
| Shares Outstanding | 44.54M | 39.40M | 24.49M | 19.17M | 14.53M | 14.44M | 11.41M | 295.7K | — | — |